|
Name |
Isoterpinolene
|
Molecular Formula | C10H16 | |
IUPAC Name* |
3-methyl-6-propan-2-ylidenecyclohexene
|
|
SMILES |
CC1CCC(=C(C)C)C=C1
|
|
InChI |
InChI=1S/C10H16/c1-8(2)10-6-4-9(3)5-7-10/h4,6,9H,5,7H2,1-3H3
|
|
InChIKey |
CIPXOBMYVWRNLL-UHFFFAOYSA-N
|
|
Synonyms |
Isoterpinolene; 586-63-0; p-Mentha-2,4(8)-diene; 3-Methyl-6-(1-methylethylidene)cyclohexene; 2,4(8)-p-Menthadiene; Cyclohexene, 3-methyl-6-(1-methylethylidene)-; 3-methyl-6-propan-2-ylidenecyclohexene; VR4XVW6V2H; EINECS 209-579-6; UNII-VR4XVW6V2H; p-2,4(8)-Menthadiene; para-Mentha-2,4(8)-diene; CHEBI:88840; DTXSID80862244; 3-Isopropylidene-6-methyl-cyclohexene; 3-Methyl-6-(1-methylethylidene)-cyclohexene; 3-Methyl-6-(1-methylethylidene)-1-cyclohexene #; Q24514387
|
|
CAS | 586-63-0 | |
PubChem CID | 102443 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 136.23 | ALogp: | 3.5 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 10 | QED Weighted: | 0.471 |
Caco-2 Permeability: | -4.403 | MDCK Permeability: | 0.00001900 |
Pgp-inhibitor: | 0.008 | Pgp-substrate: | 0.008 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.021 |
30% Bioavailability (F30%): | 0.005 |
Blood-Brain-Barrier Penetration (BBB): | 0.374 | Plasma Protein Binding (PPB): | 93.03% |
Volume Distribution (VD): | 3.917 | Fu: | 6.50% |
CYP1A2-inhibitor: | 0.427 | CYP1A2-substrate: | 0.585 |
CYP2C19-inhibitor: | 0.148 | CYP2C19-substrate: | 0.915 |
CYP2C9-inhibitor: | 0.023 | CYP2C9-substrate: | 0.493 |
CYP2D6-inhibitor: | 0.274 | CYP2D6-substrate: | 0.891 |
CYP3A4-inhibitor: | 0.088 | CYP3A4-substrate: | 0.579 |
Clearance (CL): | 11.686 | Half-life (T1/2): | 0.692 |
hERG Blockers: | 0.033 | Human Hepatotoxicity (H-HT): | 0.431 |
Drug-inuced Liver Injury (DILI): | 0.117 | AMES Toxicity: | 0.012 |
Rat Oral Acute Toxicity: | 0.061 | Maximum Recommended Daily Dose: | 0.747 |
Skin Sensitization: | 0.928 | Carcinogencity: | 0.84 |
Eye Corrosion: | 0.603 | Eye Irritation: | 0.935 |
Respiratory Toxicity: | 0.928 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001082 | 0.333 | D0F1UL | 0.197 | ||||
ENC002403 | 0.317 | D0K7LU | 0.188 | ||||
ENC002234 | 0.308 | D0W6DG | 0.181 | ||||
ENC000383 | 0.286 | D0O1UZ | 0.169 | ||||
ENC000395 | 0.286 | D0H1QY | 0.167 | ||||
ENC001813 | 0.283 | D0WO8W | 0.167 | ||||
ENC000965 | 0.273 | D04CSZ | 0.167 | ||||
ENC001825 | 0.259 | D0P0HT | 0.165 | ||||
ENC002138 | 0.259 | D0TY5N | 0.164 | ||||
ENC002860 | 0.256 | D01JMC | 0.164 |